Boston Scientific
671 hedge funds and large institutions have $41.7B invested in Boston Scientific in 2018 Q2 according to their latest regulatory filings, with 96 funds opening new positions, 224 increasing their positions, 226 reducing their positions, and 56 closing their positions.
72% more call options, than puts
Call options by funds: $235M | Put options by funds: $136M
71% more first-time investments, than exits
New positions opened: 96 | Existing positions closed: 56
22% more capital invested
Capital invested by funds: $34.3B → $41.7B (+$7.42B)
7% more funds holding in top 10
Funds holding in top 10: 14 → 15 (+1)
6% more funds holding
Funds holding: 633 → 671 (+38)
1.39% more ownership
Funds ownership: 91.23% → 92.63% (+1.4%)
1% less repeat investments, than reductions
Existing positions increased: 224 | Existing positions reduced: 226
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$444M |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$141M |
| 3 |
Morgan Stanley
New York
|
+$121M |
| 4 |
EIP
Epoch Investment Partners
New York
|
+$107M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$103M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EVM
Eaton Vance Management
Boston,
Massachusetts
|
-$224M |
| 2 |
Two Sigma Advisers
New York
|
-$137M |
| 3 |
Millennium Management
New York
|
-$131M |
| 4 |
D.E. Shaw & Co
New York
|
-$105M |
| 5 |
Two Sigma Investments
New York
|
-$78.3M |
BSX Hedge Fund Activity: Q2 2018 in Review
671 of the 4,368 institutional investors tracked by Wall St. Rank reported a position in Boston Scientific (BSX) for Q2 2018, worth a combined $41.7B — up 22% from $34.3B a quarter earlier.
Buyers outnumbered sellers: 96 funds opened new BSX positions and 56 closed out — a net gain of 40 holders — while 224 added to existing stakes and 226 trimmed.
The largest buyer was Fidelity Investments, adding an estimated $444M. The largest seller was Eaton Vance Management, cutting an estimated $224M.
- 671 institutional investors held Boston Scientific (BSX) as of Q2 2018, up from 633 in Q1 2018.
- Funds reported $41.7B of Boston Scientific stock for Q2 2018, up 22% quarter-over-quarter.
- 96 funds opened new Boston Scientific positions in Q2 2018 and 56 closed out, a net change of +40 holders.
- The largest Boston Scientific buyer in Q2 2018 was Fidelity Investments, an estimated $444M added.
- The largest Boston Scientific seller in Q2 2018 was Eaton Vance Management, an estimated $224M sold.
Based on aggregated 13F filings for Q2 2018.